Tanaka T - Search Results

1

Multistage Mesoporous Silicon-based Nanocarriers: Biocompatibility with Immune Cells and Controlled Degradation in Physiological Fluids.

Godin B, Gu J, Serda RE, Ferrati S, Liu X, Chiappini C, Tanaka T, Decuzzi P, Ferrari M. Godin B, et al. Among authors: tanaka t. Controll Release Newsl. 2008 Jan 1;25(4):9-11. Controll Release Newsl. 2008. PMID: 21853161 Free PMC article. No abstract available.

2

Size and shape effects in the biodistribution of intravascularly injected particles.

Decuzzi P, Godin B, Tanaka T, Lee SY, Chiappini C, Liu X, Ferrari M. Decuzzi P, et al. Among authors: tanaka t. J Control Release. 2010 Feb 15;141(3):320-7. doi: 10.1016/j.jconrel.2009.10.014. Epub 2009 Oct 27. J Control Release. 2010. PMID: 19874859

3

Sustained small interfering RNA delivery by mesoporous silicon particles.

Tanaka T, Mangala LS, Vivas-Mejia PE, Nieves-Alicea R, Mann AP, Mora E, Han HD, Shahzad MM, Liu X, Bhavane R, Gu J, Fakhoury JR, Chiappini C, Lu C, Matsuo K, Godin B, Stone RL, Nick AM, Lopez-Berestein G, Sood AK, Ferrari M. Tanaka T, et al. Cancer Res. 2010 May 1;70(9):3687-96. doi: 10.1158/0008-5472.CAN-09-3931. Cancer Res. 2010. PMID: 20430760 Free PMC article.

4

Tailoring the degradation kinetics of mesoporous silicon structures through PEGylation.

Godin B, Gu J, Serda RE, Bhavane R, Tasciotti E, Chiappini C, Liu X, Tanaka T, Decuzzi P, Ferrari M. Godin B, et al. Among authors: tanaka t. J Biomed Mater Res A. 2010 Sep 15;94(4):1236-43. doi: 10.1002/jbm.a.32807. J Biomed Mater Res A. 2010. PMID: 20694990 Free PMC article.

5

In vivo evaluation of safety of nanoporous silicon carriers following single and multiple dose intravenous administrations in mice.

Tanaka T, Godin B, Bhavane R, Nieves-Alicea R, Gu J, Liu X, Chiappini C, Fakhoury JR, Amra S, Ewing A, Li Q, Fidler IJ, Ferrari M. Tanaka T, et al. Int J Pharm. 2010 Dec 15;402(1-2):190-7. doi: 10.1016/j.ijpharm.2010.09.015. Epub 2010 Sep 29. Int J Pharm. 2010. PMID: 20883755 Free PMC article.

6

Proteomic analysis of serum opsonins impacting biodistribution and cellular association of porous silicon microparticles.

Serda RE, Blanco E, Mack A, Stafford SJ, Amra S, Li Q, van de Ven A, Tanaka T, Torchilin VP, Wiktorowicz JE, Ferrari M. Serda RE, et al. Among authors: tanaka t. Mol Imaging. 2011 Feb;10(1):43-55. Mol Imaging. 2011. PMID: 21303614 Free PMC article.

7

Nanotechnology for breast cancer therapy.

Tanaka T, Decuzzi P, Cristofanilli M, Sakamoto JH, Tasciotti E, Robertson FM, Ferrari M. Tanaka T, et al. Biomed Microdevices. 2009 Feb;11(1):49-63. doi: 10.1007/s10544-008-9209-0. Biomed Microdevices. 2009. PMID: 18663578 Review.

8

E-selectin-targeted porous silicon particle for nanoparticle delivery to the bone marrow.

Mann AP, Tanaka T, Somasunderam A, Liu X, Gorenstein DG, Ferrari M. Mann AP, et al. Among authors: tanaka t. Adv Mater. 2011 Sep 22;23(36):H278-82. doi: 10.1002/adma.201101541. Epub 2011 Aug 11. Adv Mater. 2011. PMID: 21833996 No abstract available.

9

Identification of thioaptamer ligand against E-selectin: potential application for inflamed vasculature targeting.

Mann AP, Somasunderam A, Nieves-Alicea R, Li X, Hu A, Sood AK, Ferrari M, Gorenstein DG, Tanaka T. Mann AP, et al. Among authors: tanaka t. PLoS One. 2010 Sep 30;5(9):e13050. doi: 10.1371/journal.pone.0013050. PLoS One. 2010. PMID: 20927342 Free PMC article.

10

Mesoporous silicon particles for sustained gene silencing.

Hasan N, Mann A, Ferrari M, Tanaka T. Hasan N, et al. Among authors: tanaka t. Methods Mol Biol. 2013;1049:481-93. doi: 10.1007/978-1-62703-547-7_36. Methods Mol Biol. 2013. PMID: 23913239

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

17,377 results

Search Page

Filters